Ashland board authorizes quarterly dividend
The board of directors of Ashland has declared a quarterly cash dividend of $0.335 per share on its common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
The board of directors of Ashland has declared a quarterly cash dividend of $0.335 per share on its common stock. This dividend will be payable on March 15, 2023, to stockholders of record as of March 1, 2023.
As of December 31, 2022, Ashland had 54,271,587 shares of common stock outstanding. Ashland operates globally in additives and specialty ingredients, serving various markets including construction, energy, and pharmaceuticals, with a focus on environmental, social, and governance (ESG) practices.
Positive
- Quarterly cash dividend declared at $0.335 per share, enhancing shareholder value.
- Company demonstrates commitment to ESG practices, potentially attracting socially conscious investors.
Negative
- None.
Details
News Market Reaction – ASH
The recorded move for ASH in the trading session of this news was +0.40%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WILMINGTON, Del., Jan. 23, 2023 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of
As of December 31, 2022, there were 54,271,587 shares of Ashland common stock outstanding.
About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environment, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceutical. Approximately 3,900 passionate, tenacious solvers thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit ashland.com and ashland.com/ESG to learn more.
™ Trademark, Ashland or its subsidiaries, registered in various countries.
| Investor Relations: | Media Relations: |
| Seth A. Mrozek | Carolmarie C. Brown |
| +1 (302) 594-5010 | +1 (302) 995-3158 |
| samrozek@ashland.com | ccbrown@ashland.com |
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.